Nuclear deoxyribonucleic acid ploidy in squamous cell bladder cancer.

Area of Science:

• Urology
• Oncology
• Pathology

Background:

• Squamous cell carcinoma of the bladder is a significant cause of cancer-related mortality.
• Accurate prognostic markers are crucial for effective patient management and treatment stratification.
• Nuclear deoxyribonucleic acid (DNA) content analysis offers a potential objective measure of tumor characteristics.

Purpose of the Study:

• To evaluate the prognostic significance of nuclear DNA content in primary squamous cell bladder carcinomas.
• To correlate DNA ploidy patterns with tumor grade, stage, and patient outcomes.

Main Methods:

• Flow cytometric analysis of nuclear DNA content was performed on 76 archival paraffin-embedded primary squamous cell bladder carcinomas.
• Tumors were classified based on DNA ploidy patterns: diploid, tetraploid (4C peak), or aneuploid.
• Patients were followed for a median of 10.1 years to assess disease-free rates and survival.

Main Results:

• Of 73 evaluable tumors, 37% were diploid, 23% tetraploid, and 40% aneuploid.
• High-grade and high-stage tumors showed a significantly higher incidence of abnormal DNA patterns (tetraploid or aneuploid).
• Patients with diploid tumors had significantly better 5- and 10-year disease-free rates (67%) compared to those with abnormal ploidy (22-18%).

Conclusions:

• Nuclear DNA ploidy, as measured by flow cytometry, is a significant objective prognostic variable in squamous cell carcinoma of the bladder.
• Abnormal DNA ploidy patterns (tetraploid and aneuploid) are associated with significantly worse survival rates.
• DNA ploidy analysis can aid in stratifying patients and predicting outcomes for bladder cancer.